Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice
- PMID: 36057735
- DOI: 10.1007/s11011-022-01075-5
Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice
Abstract
Cholinergic, oxidative, nitrergic alterations, and neuroinflammation are some key neuropathological features common in schizophrenia disease. They involve complex biological processes that alter normal behavior. The present treatments used in the management of the disorder remain ineffective together with some serious side effects as one of their setbacks. Taurine is a naturally occurring essential β-amino acid reported to elicit antipsychotic property in first episode psychosis in clinical setting, thus require preclinical investigation. Hence, we set out to investigate the effects of taurine in the prevention and reversal of ketamine-induced psychotic-like behaviors and the associated putative neurobiological mechanisms underlying its effects. Adult male Swiss mice were sheared into three separate cohorts of experiments (n = 7): drug alone, preventive and reversal studies. Treatments consisted of saline (10 mL/kg/p.o./day), taurine (50 and 100 mg/kg/p.o./day) and risperidone (0.5 mg/kg/p.o./day) with concomitant ketamine (20 mg/kg/i.p./day) injections between days 8-14, or 14 days entirely. Behavioral hyperactivity, despair, cognitive impairment, and catalepsy were measured. Brain oxidative/nitrergic imbalance, immunoreactivity (COX-2 and iNOS), and cholinergic markers were determined in the striatum, prefrontal-cortex, and hippocampus. Taurine abates ketamine-mediated psychotic-like episodes without cataleptogenic potential. Taurine attenuated ketamine-induced decrease in glutathione, superoxide-dismutase and catalase levels in the striatum, prefrontal-cortex and hippocampus. Also, taurine prevented and reversed ketamine-mediated elevation of malondialdehyde, nitrite contents, acetylcholinesterase activity, and suppressed COX-2 and iNOS expressions in a brain-region dependent manner. Conclusively, taurine insulates against ketamine-mediated psychotic phenotype by normalizing brain central cholinergic neurotransmissions, oxidative, nitrergic and suppression of immunoreactive proteins in mice brains.
Keywords: Amino acids; Cholinergic deficit; Cognitive deficits; Neuroinflammation; Schizophrenia.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Prevention and reversal of ketamine-induced experimental psychosis in mice by the neuroactive flavonoid, hesperidin: The role of oxidative and cholinergic mechanisms.Brain Res Bull. 2021 Dec;177:239-251. doi: 10.1016/j.brainresbull.2021.10.007. Epub 2021 Oct 12. Brain Res Bull. 2021. PMID: 34653559
-
Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.Neurochem Res. 2023 Mar;48(3):816-829. doi: 10.1007/s11064-022-03808-5. Epub 2022 Nov 9. Neurochem Res. 2023. PMID: 36350433
-
Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.Mol Biol Rep. 2021 Mar;48(3):2335-2350. doi: 10.1007/s11033-021-06264-6. Epub 2021 Apr 3. Mol Biol Rep. 2021. PMID: 33811574
-
[Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?].Encephale. 2007 Sep;33(4 Pt 1):616-20. doi: 10.1016/s0013-7006(07)92062-x. Encephale. 2007. PMID: 18033152 Review. French.
-
Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.Redox Biol. 2019 Jun;24:101223. doi: 10.1016/j.redox.2019.101223. Epub 2019 May 21. Redox Biol. 2019. PMID: 31141786 Free PMC article. Review.
Cited by
-
The protective role of ginsenoside Rg3 in heart diseases and mental disorders.Front Pharmacol. 2024 Feb 26;15:1327033. doi: 10.3389/fphar.2024.1327033. eCollection 2024. Front Pharmacol. 2024. PMID: 38469409 Free PMC article. Review.
-
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission.IBRO Neurosci Rep. 2024 Jan 3;16:86-97. doi: 10.1016/j.ibneur.2023.12.008. eCollection 2024 Jun. IBRO Neurosci Rep. 2024. PMID: 38282757 Free PMC article.
-
Jobelyn® improves motor dysfunctions induced by haloperidol in mice via neuroprotective mechanisms relating to modulation of cAMP response-element binding protein and mitogen-activated protein kinase.Metab Brain Dis. 2023 Oct;38(7):2269-2280. doi: 10.1007/s11011-023-01253-z. Epub 2023 Jun 22. Metab Brain Dis. 2023. PMID: 37347426
-
Mechanisms underlying methamphetamine-induced disruption of testicular integrity.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 2. doi: 10.1007/s00210-025-04311-8. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40600989 Review.
-
Diosgenin alleviates alcohol-mediated escalation of social defeat stress and the neurobiological sequalae.Psychopharmacology (Berl). 2024 Apr;241(4):785-803. doi: 10.1007/s00213-023-06509-1. Epub 2024 Feb 5. Psychopharmacology (Berl). 2024. PMID: 38311692
References
-
- Attari A, Mojdeh A, Khalifeh, Soltani FAS, Najarzadegan MR (2017) Aspirin inclusion in antipsychotic treatment on severity of symptoms in schizophrenia: a randimized clinical trial. Iran J Psychiatry Behav Sci 2017(11):e5848
-
- Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318:1645–1647. https://doi.org/10.1126/science.1148045 - DOI - PubMed
-
- Ben-Azu B, Aderibigbe AO, Ajayi AM, Iwalewa EO (2016) Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice. Pharm Biol 54:2871–2879. https://doi.org/10.1080/13880209.2016.1190382 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials